FDA Approves First Cannabis-Derived Drug for Treatment of Seizures

Posted by The Evidence Blog on July 5, 2018

The Food and Drug Administration (FDA) last week approved Epidiolex (cannabidiol; GW Pharmaceuticals) for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana; it’s also the first FDA approval of a drug for the treatment of patients with Dravet syndrome.

Read More

Topics: FDA approval, Epidiolex

Sign up to receive updates from our blog

Our latest articles

New Call-to-action